BioXcel Therapeutics, Inc. Return On Assets in % from Q3 2018 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
BioXcel Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2018 to Q3 2025.
  • BioXcel Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2025 was -185 %, a 76.1% decline year-over-year.
  • BioXcel Therapeutics, Inc. annual Return On Assets for 2024 was -101 %, a 30% increase from 2023.
  • BioXcel Therapeutics, Inc. annual Return On Assets for 2023 was -145 %, a 98.8% decline from 2022.
  • BioXcel Therapeutics, Inc. annual Return On Assets for 2022 was -72.9 %, a 67.3% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)

BioXcel Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -185 -80 -76.1% Jul 1, 2025 Sep 30, 2025
Q2 2025 -134 -0.46 -0.34% Apr 1, 2025 Jun 30, 2025
Q1 2025 -83.8 +70.6 +45.7% Jan 1, 2025 Mar 31, 2025
Q4 2024 -101 +43.4 +30% Oct 1, 2024 Dec 31, 2024
Q3 2024 -105 +30.1 +22.3% Jul 1, 2024 Sep 30, 2024
Q2 2024 -134 -28.7 -27.2% Apr 1, 2024 Jun 30, 2024
Q1 2024 -154 -69.2 -81.3% Jan 1, 2024 Mar 31, 2024
Q4 2023 -145 -72 -98.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 -135 -77 -132% Jul 1, 2023 Sep 30, 2023
Q2 2023 -105 -54.4 -107% Apr 1, 2023 Jun 30, 2023
Q1 2023 -85.1 -40 -88.6% Jan 1, 2023 Mar 31, 2023
Q4 2022 -72.9 -29.3 -67.3% Oct 1, 2022 Dec 31, 2022
Q3 2022 -58.1 -15.8 -37.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 -50.9 -8.39 -19.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 -45.1 +6.21 +12.1% Jan 1, 2022 Mar 31, 2022
Q4 2021 -43.5 +9.9 +18.5% Oct 1, 2021 Dec 31, 2021
Q3 2021 -42.3 +22 +34.2% Jul 1, 2021 Sep 30, 2021
Q2 2021 -42.5 +48.3 +53.2% Apr 1, 2021 Jun 30, 2021
Q1 2021 -51.3 +29.9 +36.8% Jan 1, 2021 Mar 31, 2021
Q4 2020 -53.5 +31.8 +37.3% Oct 1, 2020 Dec 31, 2020
Q3 2020 -64.3 +14.2 +18.1% Jul 1, 2020 Sep 30, 2020
Q2 2020 -90.8 -24.2 -36.3% Apr 1, 2020 Jun 30, 2020
Q1 2020 -81.3 -32.8 -67.5% Jan 1, 2020 Mar 31, 2020
Q4 2019 -85.3 -46.5 -120% Oct 1, 2019 Dec 31, 2019
Q3 2019 -78.5 -40.9 -109% Jul 1, 2019 Sep 30, 2019
Q2 2019 -66.6 Apr 1, 2019 Jun 30, 2019
Q1 2019 -48.5 Jan 1, 2019 Mar 31, 2019
Q4 2018 -38.7 Oct 1, 2018 Dec 31, 2018
Q3 2018 -37.6 Jul 1, 2018 Sep 30, 2018

BioXcel Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -101 +43.4 +30% Jan 1, 2024 Dec 31, 2024
2023 -145 -72 -98.8% Jan 1, 2023 Dec 31, 2023
2022 -72.9 -29.3 -67.3% Jan 1, 2022 Dec 31, 2022
2021 -43.5 +9.9 +18.5% Jan 1, 2021 Dec 31, 2021
2020 -53.5 +31.8 +37.3% Jan 1, 2020 Dec 31, 2020
2019 -85.3 -46.5 -120% Jan 1, 2019 Dec 31, 2019
2018 -38.7 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.